Recent

% | $
Quotes you view appear here for quick access.

công ty Questcor Pharmaceuticals Message Board

  • phil_inarizona phil_inarizona Oct 31, 2013 8:48 AM Flag

    Possible remedy for this earnings call swoon

    QCOR management has shown they are shareholder friendly and like to stick a thumb in the short's eye.
    A few members of top management should get together and coordinate some insider buying to the tune of a million or two. I am pretty sure once the public got wind of this the market cap would go up by 100-300 million (of the 500 -600 million it lost yesterday). What do you think?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • That would be great, but based on the sales we have seen, not likely to happen. I have thought about this and have come to the conclusion that I don't want to be overweight Qcor. Like it or not, the SA article has a point. The participation of two new government offices is not a good thing, and is likely not neutral, so it is likely a bad thing. The insider selling is not a good thing. Institutions reducing shares is not a good thing. The fact that the company did not buy back shares last Q and seems to be hording cash is not a good thing. We are heading into milder weather and that may slow MS sales again for the next two quarters (not a good thing). offsetting is high growth in volume, revenue, earnings and cash (I hope it is not too good to be true). Bottom line I like Qcor but am not going to overweight. Caution Will Robinson.

    • yes. as the saying goes the difference between a conversation and a commitment is a CHECK. Start writing some checks..

      Sentiment: Strong Buy

    • Double edge sword. Then SA would produce an "article" that says they knew about the problems and took advantage of the shareholders. Then here comes the ambulance chasers... Not sure how it would turn out, but it would cause a lot of drama IMO. Let the drama run its course, next week things will settle down.

 
QCOR
93.60+1.52(+1.65%)Aug 14 4:00 PMEDT